Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Nov 19, 2021 11:57am
113 Views
Post# 34146063

RE:Some people may not like this because it reflects

RE:Some people may not like this because it reflects The current book value presumes cash on hand I suspect....which is an obviously fluid variable....so right now BV = 0.44c....but in another Q it will be less.  That's why BV arguments for non-profitable businesses is a poor metric.

mcamm10 wrote: their lack of knowledge so hopefully they learn something.

The BV or book value of a company is a calculation to guide an investor.   It is a hypothetical scenario that if a company were to immediately cease to exist what is it worth when elimating all future revenue streams discounted to a present value.    You can look up the definition and BV formula. 

When we apply this formula to LABS we get a BV per share of  $.44 which reflect the value of the company today per share without any future earnings, a liquidation price or a snapshot price. 

So LABS is trading at nearly 2X's below Book Value which means it presents an "arbitrage" opportunity because it is heavily "over sold".  

It also reflects sa lack of knowledge by the newer generation of investors aged 20 to 40 because technology since the early 1980's has enabled a much larger portion of the population to play the stock market anywhere at anytime but what did not accompany the technial "enabler" was the required education, formal or self taught, to understand how companies are valued and how the stock market works.   

So if you invest $5 million today in LABS at it's existing price, any news "waking up" investors can easily double your money.

I could have been rude and said, "sheep for the shearing".  




<< Previous
Bullboard Posts
Next >>